 BNET |
Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies
BNET Facet Investors: On what planet is a package containing a Phase III-ready potential blockbuster multiple sclerosis drug, four clinical-stage cancer drugs, ... Moody's affirms 'Negative' outlook for Abbott Abbott To Buy Facet For $722 Mln, Adding To Pipeline Facet Biotech Stock Soars on Abbott Bid |
Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies - BNET
Submitted by synapse on
Add new comment